GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Shares Buyback Ratio %

ME Therapeutics Holding (XCNQ:METX) Shares Buyback Ratio % : 0.00 (As of Jun. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. ME Therapeutics Holding's current shares buyback ratio was 0.00%.


ME Therapeutics Holding Shares Buyback Ratio % Historical Data

The historical data trend for ME Therapeutics Holding's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Shares Buyback Ratio % Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Shares Buyback Ratio %
- -1.66

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Shares Buyback Ratio % Get a 7-Day Free Trial - -1.66 - - -0.31

ME Therapeutics Holding Shares Buyback Ratio % Calculation

ME Therapeutics Holding's Shares Buyback Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Aug. 2022 ) - Shares Outstanding (EOP) (A: Aug. 2023 )) / Shares Outstanding (EOP) (A: Aug. 2022 )
=(23.176 - 23.5611) / 23.176
=-1.66%

ME Therapeutics Holding's Shares Buyback Ratio for the quarter that ended in Feb. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Nov. 2023 ) - Shares Outstanding (EOP) (A: Feb. 2024 )) / Shares Outstanding (EOP) (A: Nov. 2023 )
=(23.5612 - 23.6345) / 23.5612
=-0.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ME Therapeutics Holding Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines